Izinsongo eziningi zegciwane lokuphefumula ebusika
Izinyathelo zokunciphisa ukudluliswa kwe-SARS-CoV-2 nazo zisebenze kahle ekunciphiseni ukudluliswa kwamanye amagciwane okuphefumula avamile. Njengoba amazwe amaningi enciphisa ukusetshenziswa kwalezi zinyathelo, i-SARS-CoV-2 izojikeleza namanye amagciwane okuphefumula, okwandisa amathuba okutheleleka kanyekanye.
Ochwepheshe babikezela ukuthi kungase kube nobhubhane lwegciwane oluphindwe kathathu kulobu busika ngenxa yokuhlanganiswa kweziqongo zesizini ze-influenza (Flu) kanye negciwane le-respiratory syndrome (RSV) kanye nobhubhane lwegciwane le-SARS-CoV-2. Inani lamacala e-Flu kanye ne-RSV kulo nyaka selivele liphezulu kunelesikhathi esifanayo eminyakeni edlule. Izinhlobo ezintsha ze-BA.4 kanye ne-BA.5 zegciwane le-SARS-CoV-2 ziye zandisa ubhubhane futhi.
Engqungqutheleni ethi "Usuku Lomhlaba Lomkhuhlane Ka-2022" ngoNovemba 1, 2022, uZhong Nanshan, isazi se-Chinese Academy of Engineering, uhlaziye ngokuphelele isimo somkhuhlane ekhaya nakwamanye amazwe, futhi wenza ucwaningo lwakamuva kanye nokwahlulela ngesimo samanje."Umhlaba usabhekene nengozi yezifo eziwumshayabhuqe ezibangelwa ubhubhane lwegciwane le-SARS-CoV-2 kanye nobhubhane lomkhuhlane." waveza ukuthi, "Ikakhulukazi kulobu busika, kusadingeka kuqiniswe ucwaningo ngezinkinga zesayensi zokuvimbela nokulawula umkhuhlane."Ngokwezibalo ze-US CDC, inani labantu abavakashela izibhedlela ngenxa yezifo zokuphefumula e-United States likhuphuke kakhulu ngenxa yokuhlanganiswa komkhuhlane kanye nokutheleleka okusha kwenhliziyo.
Ukwanda kokutholwa kwe-RSV kanye nokuvakashelwa kweminyango yezimo eziphuthumayo ehlobene ne-RSV kanye nokulaliswa esibhedlela ezifundeni eziningi zase-US, kanti ezinye izifunda zisondela emazingeni aphezulu kakhulu esizini. Njengamanje, inani lamacala okutheleleka nge-RSV e-US selifinyelele esicongweni esiphezulu eminyakeni engama-25, okwenza izibhedlela zezingane zigcwale kakhulu, kanti ezinye izikole zivaliwe.
Ubhubhane lomkhuhlane luqale e-Australia ngo-Ephreli kulo nyaka futhi lwahlala cishe izinyanga ezi-4. Kusukela ngomhlaka-25 Septhemba, kwakunamacala omkhuhlane angu-224,565 aqinisekiswe elabhorethri, okwaholela ekufeni okuhlobene okungu-305. Ngokuphambene nalokho, ngaphansi kwezinyathelo zokuvimbela ubhubhane lwegciwane le-SARS-CoV-2, kuzoba namacala omkhuhlane angaba ngu-21,000 e-Australia ngo-2020 kanye nangaphansi kuka-1,000 ngo-2021.
Umbiko wama-35 wamasonto onke we-China Influenza Center ngo-2022 ukhombisa ukuthi inani lamacala omkhuhlane ezifundazweni ezisenyakatho beliphezulu kunezinga lesikhathi esifanayo ngo-2019-2021 amasonto amane alandelanayo, futhi isimo esizayo sizoba sibucayi kakhulu. Kusukela maphakathi noJuni, inani lamacala afana nomkhuhlane abikwe eGuangzhou lenyuke ngezikhathi eziyi-10.38 uma kuqhathaniswa nonyaka odlule.
Imiphumela yocwaningo lwamamodeli oluqhutshwa emazweni ayi-11 olukhishwe yi-Lancet Global Health ngo-Okthoba ibonise ukuthi ukuthambekela kwabantu bamanje ekuhlaselweni yi-flu kukhuphuke ngamaphesenti afinyelela ku-60 uma kuqhathaniswa nangaphambi kwalesi sifo. Iphinde yabikezela ukuthi ukuphakama okuphezulu kwesizini yomkhuhlane ka-2022 kuzokwanda ngokuphindwe ka-1-5, kanti ubukhulu bobhubhane buzokwanda ngokuphindwe ka-1-4.
Abantu abadala abangu-212,466 abangenwe yi-SARS-CoV-2 abangeniswe esibhedlela. Ukuhlolwa kokutheleleka okubangelwa yi-viral yokuphefumula kwaqoshwa ezigulini ezingu-6,965 ezine-SARS-CoV-2. Ukutheleleka okubangelwa yi-viral kwatholakala ezigulini ezingu-583 (8·4%): iziguli ezingu-227 zazinamagciwane omkhuhlane, iziguli ezingu-220 zazinamagciwane okuphefumula ahambisanayo, kanti iziguli ezingu-136 zazinamagciwane e-adenovirus.
Ukutheleleka ngamagciwane omkhuhlane kanyekanye kuhlotshaniswa nokwanda kwamathuba okuthola umoya ongenisayo ngomshini uma kuqhathaniswa nokutheleleka ngamagciwane omkhuhlane kanye ne-SARS-CoV-2. Ukutheleleka ngamagciwane omkhuhlane kanye ne-SARS-CoV-2 kanye ne-adenovirus kanye nama-adenovirus kwahlotshaniswa kakhulu nokwanda kwamathuba okufa. I-OR yokuphefumula komshini ongenisayo ngomshini ongenisayo ngomkhuhlane kanye ne-influenza kwakungu-4.14 (95% CI 2.00-8.49, p=0.0001). I-OR yokufa esibhedlela ezigulini ezine-influenza kanyekanye yayingu-2.35 (95% CI 1.07-5.12, p=0.031). I-OR yokufa esibhedlela ezigulini ezine-adenovirus kanyekanye yayingu-1.6 (95% CI 1.03-2.44, p=0.033).
Imiphumela yalolu cwaningo isitshela ngokusobala ukuthi ukutheleleka kanyekanye negciwane le-SARS-CoV-2 kanye negciwane lomkhuhlane kuyisimo esiyingozi kakhulu.
Ngaphambi kokuqubuka kwe-SARS-CoV-2, izimpawu zamagciwane okuphefumula ahlukene zazifana kakhulu, kodwa izindlela zokwelapha zazihlukile. Uma iziguli zingathembeli ekuhlolweni okuningi, ukwelashwa kwamagciwane okuphefumula kuzoba nzima kakhulu, futhi kuzochitha kalula izinsiza zesibhedlela ngezikhathi zokwanda kwezifo. Ngakho-ke, ukuhlolwa okuningi kwamalunga kudlala indima ebalulekile ekuxilongweni kwezokwelapha, futhi odokotela bayakwazi ukunikeza ukuxilongwa okuhlukile kwamagciwane ezigulini ezinezimpawu zokuphefumula ngesampula eyodwa ye-swab.
Isixazululo Sokuthola Ukuphefumula Okuhlanganisiwe Okune-Macro & Micro-Test SARS-CoV-2
I-Macro & Micro-Test inamapulatifomu obuchwepheshe afana ne-fluorescent quantitative PCR, i-isothermal amplification, i-immunity, kanye ne-molecular POCT, futhi inikeza imikhiqizo eyahlukahlukene yokuthola amalunga okuphefumula e-SARS-CoV-2. Yonke imikhiqizo ithole isitifiketi se-EU CE, ngokusebenza kahle komkhiqizo kanye nesipiliyoni esihle somsebenzisi.
1. Ikhithi ye-RT-PCR ye-fluorescent yesikhathi sangempela yokuthola izinhlobo eziyisithupha zamagciwane okuphefumula
Ukulawula Kwangaphakathi: Qapha ngokugcwele inqubo yokuhlola ukuqinisekisa ikhwalithi yokuhlolwa.
Ukusebenza Kahle Okuphezulu: I-PCR yesikhathi sangempela ye-Multiplex ithola izisulu ezahlukene eziqondene ngqo ne-SARS-CoV-2, i-Flu A, i-Flu B, i-Adenovirus, i-Mycoplasma pneumoniae, kanye ne-Respiratory syncytial virus.
Ukuzwela okuphezulu: Amakhophi angu-300/mL e-SARS-CoV-2, amakhophi angu-500/mL egciwane le-influenza A, amakhophi angu-500/mL egciwane le-influenza B, amakhophi angu-500/mL egciwane le-respiratory syncytial, amakhophi angu-500/mL e-mycoplasma pneumoniae, kanye namakhophi angu-500/mL egciwane le-adenovirus.
2. Ikhithi Yokuthola I-SARS-CoV-2/Influenza A/Influenza B Nucleic Acid Combined (i-Fluorescence PCR)
Ukulawula Kwangaphakathi: Qapha ngokugcwele inqubo yokuhlola ukuqinisekisa ikhwalithi yokuhlolwa.
Ukusebenza Kahle Okuphezulu: I-PCR ye-Multiplex real-time ithola izisulu ezahlukene ze-SARS-CoV-2, i-Flu A kanye ne-Flu B.
Ukuzwela okuphezulu: Amakhophi angu-300/mL e-SARS-CoV-2,500Amakhophi/mL e-lFV A kanye namakhophi angu-500/mL e-lFV B.
3. I-SARS-CoV-2, i-Influenza A kanye ne-Influenza B Antigen Detection Kit (Immunochromatography)
Kulula Ukuyisebenzisa
Izinga Lokushisa Legumbi Ukuthuthwa kanye nokugcinwa ku-4-30°℃
Ukuzwela okuphezulu kanye nokucaciswa
| Igama Lomkhiqizo | Imininingwane |
| Ikhithi ye-RT-PCR ye-fluorescent yesikhathi sangempela yokuthola izinhlobo eziyisithupha zamagciwane okuphefumula | Ukuhlolwa okungu-20/ikhithi,Ukuhlolwa okungu-48/ikhithi,Ukuhlolwa okungu-50/ikhithi |
| Ikhithi Yokuthola I-SARS-CoV-2/Umkhuhlane A/Umkhuhlane B Nucleic Acid Combined (i-Fluorescence PCR) | Ukuhlolwa okungu-48/ikhithi,Ukuhlolwa okungu-50/ikhithi |
| I-SARS-CoV-2, i-Influenza A kanye ne-Influenza B Antigen Detection Kit (Immunochromatography) | Isivivinyo/ikhithi eli-1,Ukuhlolwa okungu-20/ikhithi |
Isikhathi sokuthunyelwe: Disemba-09-2022